• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Rockley Photonics Holdings Limited

    6/13/22 4:16:15 PM ET
    $RKLY
    Semiconductors
    Technology
    Get the next $RKLY alert in real time by email
    SC 13G 1 brhc10038659_sc13g.htm SC 13G

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, DC 20549
    SCHEDULE 13G
     
    Under the Securities Exchange Act of 1934
    (Amendment No. )*
     
    Rockley Photonics Holdings Limited
    (Name of Issuer)
    Ordinary shares, $0.000004026575398 par value per share
    (Title of Class of Securities)
    G7614L109
    (CUSIP Number)
    May 26, 2022
    (Date of Event Which Requires Filing of this Statement)
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)
    ☒ Rule 13d-1(c)
    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).



    CUSIP No.
    G7614L109  
     

    1
    NAMES OF REPORTING PERSONS
     
     
    Wazee Street Capital Management LLC
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☒
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    Delaware
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
    0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
    14,317,982 (see item 4)
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
    0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
    14,317,982 (see item 4)
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    14,317,982 (see item 4)
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
    9.99% (see item 4)
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    IA, OO
     
     
     
     


    CUSIP No.
    G7614L109  
     

    1
    NAMES OF REPORTING PERSONS
     
     
    Wazee Street Opportunities Fund V LP
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☒
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    Delaware
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
    0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
    14,317,982 (see item 4)
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
    0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
    14,317,982 (see item 4)
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    14,317,982 (see item 4)
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
    9.99% (see item 4)
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    PN
     
     
     
     
     

    CUSIP No.
    G7614L109  
     

    1
    NAMES OF REPORTING PERSONS
     
     
    R. Michael Collins
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☒
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    United States
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
    0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
    14,317,982 (see item 4)
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
    0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
    14,317,982 (see item 4)
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    14,317,982 (see item 4)
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
    9.99% (see item 4)
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    IN, HC
     
     
     
     


    CUSIP No.
     G7614L109  
     

    Item 1.
    (a).
    Name of Issuer:
     
       
    Rockley Photonics Holdings Limited
     
     
    (b).
    Address of issuer’s principal executive offices:
     
       
    3rd Floor 1 Ashley Road, Altrincham, Cheshire, United Kingdom
     
    Item 2.
    (a).
    Name of person filing:
     
       
    This statement is filed by (i) Wazee Street Opportunities Fund V LP, a Delaware limited partnership (“Fund V”); (ii) Wazee Street Capital Management LLC, a Delaware limited liability company (“Wazee Capital”), which serves as the investment manager to Fund V; and (iii) R. Michael Collins, the controlling member Wazee Capital (“Mr. Collins” and, together with Fund V and Wazee Capital, the “Reporting Persons”).  The Reporting Persons may be deemed to share voting and dispositive power with respect to the Ordinary Shares (as defined below) reported herein.
     
     
    (b).
    Address of principal business office or, if none, residence:
     
       
    The address of the business office of the Reporting Persons is 8101 E Prentice Ave, Greenwood Village, CO 80111
     
     
    (c).
    Citizenship:
     
       
    Wazee Capital and Fund V are organized under the laws of the State of Delaware.  Mr. Collins is a United States citizen.
     
     
    (d).
    Title of class of securities:
     
       
    Ordinary shares, $0.000004026575398 par value per share (“Ordinary Shares”)
     
     
    (e).
    CUSIP No.:
     
       
    G7614L109
     
    Item 3.
    If This Statement is filed pursuant to §§.240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a
     
    (a)
    ☐
    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
     
    (b)
    ☐
    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
     
    (c)
    ☐
    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
     
    (d)
    ☐
    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
     
    (e)
    ☐
    An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
     
    (f)
    ☐
    An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
     
    (g)
    ☐
    A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
     
    (h)
    ☐
    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813);
     
    (i)
    ☐
    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
     
    (j)
    ☐
    A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
     
    (k)
    ☐
    Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:


    CUSIP No.
     G7614L109  
     

    Item 4.
    Ownership.
     
    (a)
    Amount beneficially owned:
       
    Each of the Reporting Persons is deemed to be the beneficial owner of 14,317,982 Ordinary Shares, which amount includes: (i) warrants to purchase 6,493,506 Ordinary Shares at an exercise price of $5.00 per Ordinary Share (“Warrants”); (ii) $20,000,000 principal amount of Convertible Senior Secured Notes due 2026 (“Notes”), which is convertible into 6,493,506 Ordinary Shares based on the initial conversion price of $3.08 per Ordinary Share; and (iii) the option to acquire an additional $20,000,000 principal amount of Notes, which option is exercisable for a period of 12 months following the effective date of the registration statement covering the Ordinary Shares underlying the Notes, with each of (i) through (iii) subject to the Beneficial Ownership Limitations (defined below).  The Warrants are subject to a blocker which prevents the holder from exercising the Warrants to the extent that, upon such exercise, the holder would beneficially own in excess of 9.99% of the Ordinary Shares outstanding as a result of the exercise (the “Warrant Ownership Limitation”).  The Notes are subject to a blocker which prevents the holder from converting the Notes to the extent that, upon such conversion, the holder would beneficially own in excess of 9.90% of the Ordinary Shares outstanding as a result of the conversion  (the “Notes Ownership Limitation” and, together with the Warrant Ownership Limitation, the “Beneficial Ownership Limitations”).
     
    (b)
    Percent of class:
       
    Each of the Reporting Persons is deemed to beneficially own approximately 9.99% of the Ordinary Shares.
    Percent of class is calculated based on 129,005,167 Ordinary Shares outstanding as of May 5, 2022, as reported in the Issuer’s Form 8-K filed on May 12, 2022, plus the total number of Ordinary Shares that the Reporting Persons have the right to acquire upon conversion of Notes and exercise of Warrants, subject to the Beneficial Ownership Limitations, which amount has been added to the Ordinary Shares outstanding in accordance with Rule 13d-3(d)(i)(1) under the Act.
     
    (c)
    Number of shares as to which the person has:
       
    (i)
    Sole power to vote or to direct the vote
    0
     
       
    (ii)
    Shared power to vote or to direct the vote
    14,317,982
     
       
    (iii)
    Sole power to dispose or to direct the disposition of
    0
     
       
    (iv)
    Shared power to dispose or to direct the disposition of
    14,317,982
     
    Item 5.
    Ownership of Five Percent or Less of a Class.
     
    If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]
    Item 6.
    Ownership of More Than Five Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    See disclosure in Item 2(a) hereof.
    Item 8.
    Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.
    Notice of Dissolution of Group.
     
    Not Applicable
    Item 10.
    Certification.
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.


    CUSIP No.
     G7614L109  
     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: June 13, 2022

     
    R. Michael Collins
     
    Wazee Street Capital Management LLC
     
    Wazee Street Opportunities Fund V LP
     
     
    By:
    /s/ R. Michael Collins
     
    R. Michael Collins, for himself and as President and Chief Investment Officer of Wazee Street Capital Management LLC, for itself and as investment manager of Wazee Street Opportunities Fund V LP

    The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

    Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See s.240.13d-7 for other parties for whom copies are to be sent.

    Attention. Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).


    CUSIP No.
          G7614L109  
     
    Exhibit A
    AGREEMENT
    Each of the undersigned hereby consents and agrees to this joint filing to Schedule 13G for the Ordinary Shares of Rockley Photonics Holdings Limited.

    Dated: June 13, 2022

     
    R. Michael Collins
     
    Wazee Street Capital Management LLC
     
    Wazee Street Opportunities Fund V LP
       
     
    By:
    /s/ R. Michael Collins
     
    R. Michael Collins, for himself and as President and Chief Investment Officer of Wazee Street Capital Management LLC, for itself and as investment manager of Wazee Street Opportunities Fund V LP



    Get the next $RKLY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RKLY

    DatePrice TargetRatingAnalyst
    8/12/2022$6.00 → $2.00Outperform → Neutral
    Robert W. Baird
    3/9/2022$20.00 → $10.00Outperform
    Northland Capital Markets
    3/9/2022$6.00 → $5.00Neutral
    B of A Securities
    3/9/2022$15.00 → $8.00Buy
    Needham
    12/22/2021$14.00 → $6.00Buy → Neutral
    B of A Securities
    9/17/2021$14.00Buy
    B of A Securities
    9/9/2021$22.00Outperform
    Cowen
    9/7/2021$15.00Buy
    Needham
    More analyst ratings

    $RKLY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Rockley Photonics downgraded by Robert W. Baird with a new price target

      Robert W. Baird downgraded Rockley Photonics from Outperform to Neutral and set a new price target of $2.00 from $6.00 previously

      8/12/22 7:29:27 AM ET
      $RKLY
      Semiconductors
      Technology
    • Northland Capital Markets reiterated coverage on Rockley Photonics Hldgs with a new price target

      Northland Capital Markets reiterated coverage of Rockley Photonics Hldgs with a rating of Outperform and set a new price target of $10.00 from $20.00 previously

      3/9/22 11:07:52 AM ET
      $RKLY
      Semiconductors
      Technology
    • B of A Securities reiterated coverage on Rockley Photonics Hldgs with a new price target

      B of A Securities reiterated coverage of Rockley Photonics Hldgs with a rating of Neutral and set a new price target of $5.00 from $6.00 previously

      3/9/22 10:40:09 AM ET
      $RKLY
      Semiconductors
      Technology

    $RKLY
    Leadership Updates

    Live Leadership Updates

    See more
    • Rockley Photonics Appoints Healthcare Industry Veteran Richard A. "Randy" Meier President and Chief Financial Officer

      Meier to focus on driving cash-efficient performance and enabling commercial production ramp Rockley Photonics Holdings Limited (NYSE:RKLY) ("Rockley"), a global leader in photonics-based health monitoring and communications solutions, today announced the appointment of Richard A. "Randy" Meier as president and chief financial officer (CFO), effective immediately. Meier will shape Rockley's financial and commercialization strategies, and lead its finance, supply chain, quality, regulatory and compliance functions. An accomplished finance and operations leader with a rich background in healthcare therapeutics and medical devices, Meier joins Rockley from Intersect ENT, a leading global ear

      10/20/22 9:37:00 AM ET
      $RKLY
      Semiconductors
      Technology
    • Rockley Photonics Names Nicolaus Henke to Board of Directors

      Rockley Photonics (NYSE:RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced that it named Nicolaus Henke to its board of directors. Dr. Henke will join the board as an independent director, effective February 16, 2022, and will serve on the Nominating & Corporate Governance Committee. "I am very pleased with the appointment of Nicolaus Henke to our board. He brings a wealth of practical experience which will have an immediate impact on Rockley," said Dr. Andrew Rickman, chairman and chief executive officer of Rockley Photonics. "Throughout his career, Nico has advised top teams in leading health systems, medical device companies and pha

      2/16/22 9:05:00 AM ET
      $RKLY
      Semiconductors
      Technology
    • SpartanNash Announces Board Refreshment; Appoints Three New Independent Directors

      Julien Mininberg, Jaymin Patel and Pamela Puryear, Ph.D., Bring Significant Technology, Distribution, Consumer Brand and Human Resources Expertise Food solutions company SpartanNash (the "Company") (NASDAQ:SPTN) today announced that, following a comprehensive board refreshment process, three new independent directors, Julien Mininberg, Jaymin Patel and Pamela Puryear, Ph.D., have been appointed to the Company's Board of Directors (the "Board"), effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220207005303/en/Julien Mininberg (Photo: Business Wire) "Since last summer, our Board has undertaken a deliberate and

      2/7/22 8:15:00 AM ET
      $BALY
      $CLRM
      $HELE
      $NXGN
      Hotels/Resorts
      Consumer Discretionary
      Consumer Electronics/Appliances
      Industrials

    $RKLY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Rockley Photonics Receives 2020 UK R&D Tax Credit and Files 2021 R&D Tax Credit Application

      Rockley Photonics Holdings Limited (NYSE:RKLY) ("Rockley"), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it received 12.9 million pounds sterling ($15.5 million) for its fiscal 2020 R&D tax credit from HMRC, the tax agency of the UK government. The Company filed its fiscal 2021 R&D tax credit application and expects to file its fiscal 2022 R&D tax credit application in 2023. About Rockley Photonics Formed in 2013, Rockley is a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions that target a portfo

      12/29/22 9:05:00 AM ET
      $RKLY
      Semiconductors
      Technology
    • Rockley Photonics Announces Receipt of Notice from NYSE of Non-Compliance with Continued Listing Standards

      Rockley Photonics Holdings Limited (NYSE:RKLY) ("Rockley"), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it received a notice from the New York Stock Exchange ("NYSE") on December 9, 2022, indicating that the Company is not in compliance with NYSE's continued listing standards, which require an average market capitalization of not less than $50 million over a 30 trading-day period and stockholders' equity of not less than $50 million. The notice has no immediate impact on the listing of Rockley's common stock on the NYSE, subject to the Company's compliance wit

      12/15/22 4:15:00 PM ET
      $RKLY
      Semiconductors
      Technology
    • Rockley Photonics Announces Promotion of Richard A. (Randy) Meier to Chief Executive Officer

      Rickman to serve as executive chair; Becker promoted to interim chief financial officer Rockley Photonics Holdings Limited (NYSE:RKLY), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced changes to its senior management team. These changes are intended to position the Company for its next phase of growth. Effective immediately, Richard A. Meier has been appointed president and chief executive officer, and will join the board of directors. Dr. Andrew Rickman has resigned as chief executive officer and will take on the role of executive chairman of Rockley. Chad Becker wi

      12/12/22 4:15:00 PM ET
      $RKLY
      Semiconductors
      Technology

    $RKLY
    Financials

    Live finance-specific insights

    See more
    • Rockley Photonics Reports Third Quarter of Fiscal 2022 Financial Results

      Additional capital raised through private placement Reduction in headcount and operating costs targets lower cash burn Advanced blood pressure biomarker by demonstrating promising intra-subject tracking against standard blood pressure cuff Rockley Photonics Holdings Limited (NYSE:RKLY), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced its financial results for the third quarter ended September 30, 2022. During the quarter, the Company advanced its technology platform, Bioptx™, through several technical and clinical targets: Expanded Free-Living Human Study of Its B

      11/9/22 4:15:00 PM ET
      $RKLY
      Semiconductors
      Technology
    • Rockley Photonics Announces Date of Third Quarter 2022 Financial Results Release

      Rockley Photonics (NYSE:RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced that it plans to report its third quarter 2022 financial results after the market closes on Wednesday, November 9, 2022. The company also plans to host a conference call that day at 5:00 p.m. Eastern Time to review its financial results and business outlook. The conference call can be accessed by dialing 877-407-0832 from the United States or +1 201-689-8433 internationally, referencing Rockley Photonics. A live webcast and replay of the conference call can be accessed from the investor relations page on Rockley's website at investors.rockleyphotonics.com. Follo

      10/26/22 4:15:00 PM ET
      $RKLY
      Semiconductors
      Technology
    • Rockley Photonics Reports Second Quarter of Fiscal 2022 Financial Results

      Signs Supply Agreement and Receives First Commercial Purchase Order from Top-Tier Medtech Company for Bioptx™ Baseline Band, Targets Fourth Quarter to Begin Shipping Signs First Contract Research Organization Partnership to Develop and Evaluate Rockley's Bioptx™ Biomarker Sensing Platform for Use in Clinical Trials Bolsters Board of Directors and Establishes Scientific Advisory Board Rockley Photonics Holdings Limited (NYSE:RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced its financial results for the second quarter ended June 30, 2022. "I am proud of the progress we made in the second quarter. As we ramp towards commercial produc

      8/11/22 4:15:00 PM ET
      $RKLY
      Semiconductors
      Technology

    $RKLY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Meier Richard A

      4 - Rockley Photonics Holdings Ltd (0001852117) (Issuer)

      10/21/22 5:43:39 PM ET
      $RKLY
      Semiconductors
      Technology
    • SEC Form 3 filed by new insider Meier Richard A

      3 - Rockley Photonics Holdings Ltd (0001852117) (Issuer)

      10/21/22 5:22:44 PM ET
      $RKLY
      Semiconductors
      Technology
    • SEC Form 4 filed by Kuntz Richard

      4 - Rockley Photonics Holdings Ltd (0001852117) (Issuer)

      8/31/22 6:59:56 PM ET
      $RKLY
      Semiconductors
      Technology

    $RKLY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Rockley Photonics Holdings Limited (Amendment)

      SC 13G/A - Rockley Photonics Holdings Ltd (0001852117) (Subject)

      2/14/23 4:05:33 PM ET
      $RKLY
      Semiconductors
      Technology
    • SEC Form SC 13G filed by Rockley Photonics Holdings Limited

      SC 13G - Rockley Photonics Holdings Ltd (0001852117) (Subject)

      2/14/23 4:01:54 PM ET
      $RKLY
      Semiconductors
      Technology
    • SEC Form SC 13G filed by Rockley Photonics Holdings Limited

      SC 13G - Rockley Photonics Holdings Ltd (0001852117) (Subject)

      2/14/23 1:23:02 PM ET
      $RKLY
      Semiconductors
      Technology

    $RKLY
    SEC Filings

    See more
    • SEC Form 15-12G filed by Rockley Photonics Holdings Limited

      15-12G - Rockley Photonics Holdings Ltd (0001852117) (Filer)

      5/15/23 7:44:57 AM ET
      $RKLY
      Semiconductors
      Technology
    • SEC Form 10-K filed by Rockley Photonics Holdings Limited

      10-K - Rockley Photonics Holdings Ltd (0001852117) (Filer)

      5/15/23 7:25:35 AM ET
      $RKLY
      Semiconductors
      Technology
    • Rockley Photonics Holdings Limited filed SEC Form 8-K: Bankruptcy or Receivership, Material Modification to Rights of Security Holders, Leadership Update, Financial Statements and Exhibits

      8-K - Rockley Photonics Holdings Ltd (0001852117) (Filer)

      4/7/23 4:05:05 PM ET
      $RKLY
      Semiconductors
      Technology